Patel Parth M, Levine Dov, Dong Andy, Yamabe Tsuyoshi, Wei Jane, Binongo Jose, Leshnower Bradley G, Takayama Hiroo, Chen Edward P
Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Ga.
Division of Cardiac, Thoracic and Vascular Surgery, Department of Surgery, New York-Presbyterian/Columbia University Irving Medical Center, New York, NY.
JTCVS Open. 2023 Sep 22;16:167-176. doi: 10.1016/j.xjon.2023.08.025. eCollection 2023 Dec.
The impact of previous aortic root replacement (True-Redo) versus any previous operation (Any-Redo) on outcomes after reoperative aortic root replacement (redo-ROOT) is largely unknown. In this first multi-institutional study, the clinical impact True-Redo versus Any-Redo in the setting of redo-ROOT was reviewed.
From 2004 to 2021, 822 patients underwent redo-ROOT at 2 major academic centers: 638 Any-Redo and 184 True-Redo. Matching based on preoperative demographics and concomitant operations resulted in 174 matched pairs. An independent risk factor analysis was performed to determine risk factors for early and late mortality.
Patients in the True-Redo group were younger, at 49.9 ± 15.1 versus 55.3 ± 14.7 years, < .001. Concomitant operations were largely similar between the 2 groups, > .05. Median cardiopulmonary bypass time ( < .001) and aortic crossclamp time ( = .03) were longer for True-Redo group. In-hospital mortality was 13% (109) and was without significant difference between groups, = .41. Ten-year survival was 78% versus 76% for True-Redo versus Any-Redo groups respectively, = .7. Landmark survival analysis at 4 years' postoperatively on the matched groups found that patients in the True-Redo group had improved survival outcomes ( = .046). Risk factors of in-hospital mortality consisted of older age ( < .0001), lower ejection fraction ( = .02), and male patient ( = .0003).
Clinical outcomes following redo-ROOT are excellent. Performance of a True-Redo-ROOT does not result in worse in-hospital morbidity or mortality and has improved survival benefit at midterm follow-up when compared with patients in the Any-Redo group. The decision to perform a redo-ROOT must be taken seriously and must be individualized in a patient-specific manner for optimal outcomes.
既往主动脉根部置换术(真性再次手术)与既往任何手术(任意再次手术)对再次主动脉根部置换术(再次手术-ROOT)后结局的影响在很大程度上尚不清楚。在这项首个多机构研究中,对真性再次手术与任意再次手术在再次手术-ROOT情况下的临床影响进行了回顾。
2004年至2021年,822例患者在2个主要学术中心接受了再次手术-ROOT:638例任意再次手术和184例真性再次手术。根据术前人口统计学和同期手术进行匹配,得到174对匹配对。进行独立危险因素分析以确定早期和晚期死亡的危险因素。
真性再次手术组患者更年轻,年龄为49.9±15.1岁,而另一组为55.3±14.7岁,P<0.001。两组同期手术情况基本相似,P>0.05。真性再次手术组的中位体外循环时间(P<0.001)和主动脉阻断时间(P=0.03)更长。住院死亡率为13%(109例),两组间无显著差异,P=0.41。真性再次手术组与任意再次手术组的10年生存率分别为78%和76%,P=0.7。对匹配组术后4年进行的标志性生存分析发现,真性再次手术组患者的生存结局有所改善(P=0.046)。住院死亡的危险因素包括年龄较大(P<0.0001)、射血分数较低(P=0.02)和男性患者(P=0.0003)。
再次手术-ROOT后的临床结局良好。与任意再次手术组患者相比,进行真性再次手术-ROOT不会导致更差的住院发病率或死亡率,并且在中期随访时具有更好的生存获益。进行再次手术-ROOT的决定必须慎重做出,并且必须根据患者的具体情况进行个体化处理以获得最佳结局。